Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiolyse is a digital health company that provides a cloud-based heart health analytics platform using artificial intelligence to analyze electrocardiogram (ECG) and heart rate variability (HRV) data. The company's technology enables remote patient monitoring and provides clinicians with automated reports for early detection of cardiovascular diseases, including arrhythmias and heart failure. By leveraging machine learning algorithms, Cardiolyse offers personalized health insights and risk scores to improve patient outcomes and streamline clinical workflows. The platform is CE-marked as a Class IIa medical device, supporting its use in both clinical settings and pharmaceutical research for safety monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiolyse.